Go to Polygence Scholars page
Siri Manthapuri's cover illustration
Polygence Scholar2021
Siri Manthapuri's profile

Siri Manthapuri

Irvington High SchoolClass of 2023Fremont, California

About

Projects

  • "A Brief Overview of Pathological Tau and Inhibitors and Modifiers of Tau Aggregation for Treatment of Tauopathies" with mentor Emily (Oct. 11, 2021)

Project Portfolio

A Brief Overview of Pathological Tau and Inhibitors and Modifiers of Tau Aggregation for Treatment of Tauopathies

Started Mar. 20, 2021

Abstract or project description

Tauopathies make up a significant portion of neurodegenerative diseases, affecting tens of millions of people. Tauopathies are defined by abnormal tau protein aggregation.  Current approaches to tauopathy inhibition and therapeutic development require an in-depth understanding of post-translational modifications and propagation of pathological tau. Research thus far has produced a variety of inhibiting and mitigating compounds to alleviate tau aggregation. These compounds employ distinct mechanisms, including: kinase-, enzyme-, and secretion-inhibition, direct aggregation inhibition, and upregulation of cellular degradation systems. Overall, the current progress and ongoing research in the development of tauopathy therapeutics has potential, while also highlighting some crucial unknowns in the field that warrant further investigation.